The Petri Dish: $2.5M for another Bob Langer startup, Decibel extends Regeneron deal

While some in the life sciences industry create drugs and devices to tackle the Covid-19 pandemic, their colleagues are busy as ever raising money, testing new drugs, expanding facilities and more. Here’s The Petri Dish, a roundup of news that may get overlooked amid the influx of Greater Boston life sciences and health care happenings.
Click here to view original post